Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Rennova Health's Enterprise Value is $0.00 Mil.
Rennova Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was $3.39 Mil. Therefore, Rennova Health's EV-to-OCF for today is 0.00.
The historical rank and industry rank for Rennova Health's EV-to-OCF or its related term are showing as below:
During the past 13 years, the highest EV-to-OCF of Rennova Health was 4.73. The lowest was -5.03. And the median was .
RNVA's EV-to-OCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 5.91 * Ranked among companies with meaningful EV-to-OCF only.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Rennova Health's PE Ratio (TTM) for today is calculated as:
Rennova Health's share price for today is $0.0001.
Rennova Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Rennova Health EV-to-OCF Related Terms
Rennova Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Rennova Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Rennova Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rennova Health EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Rennova Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Rennova Health's EV-to-OCF falls into.
Rennova Health's current Enterprise Value is $0.00 Mil.
Rennova Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rennova Health (RNVA) has a EV-to-OCF of 0.00 as of Aug. 30, 2026.
Is Rennova Health's EV-to-OCF too high?
Rennova Health's current EV-to-OCF is 0.00. Overall, Rennova Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Rennova Health's EV-to-OCF compare to ISPC and CNTGF?
Rennova Health's EV-to-OCF of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. The industry median EV-to-OCF is 5.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 5.91, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 5.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rennova Health's current EV-to-OCF is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rennova Health stock overvalued right now?
Rennova Health (RNVA) has a current EV-to-OCF of 0.00. The current EV-to-OCF is 0.00. Rennova Health's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Rennova Health (RNVA), the current EV-to-OCF is 0.00 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rennova Health Inc is a vertically integrated provider of healthcare-related products and services. The company operates through a single business segment namely the Hospital operations segment reflects the purchase of the hospital assets. Geographically, the activities are carried out throughout the region of the United States.
12GF Score
Get the complete analysis for RNVA
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RNVA has been successfully added to your 
